An observational study in Catheter Ablation and Cardiac Arrhythmias, sponsored by National Cerebral and Cardiovascular Center, Japan. Recruiting at 1 site in Japan. Per ClinicalTrials.gov, last updated 2023-11-13.
Sponsored by National Cerebral and Cardiovascular Center, Japan · Observational
Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.
Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center.
This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.
885 studies on the registry are indexed under Arrhythmias, Cardiac; 234 are open to participants now.
This study's planned enrollment of 400,000 is above the median of 200 across 413 observational studies indexed under Arrhythmias, Cardiac.
Browse Arrhythmias, Cardiac studies →National Cerebral and Cardiovascular Center, Japan is the lead sponsor of 19 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inpatients
Exclusion Criteria:
Number of patients with recurrence of targeted arrhythmia
Time frame: Through discharge from hospital, approximately up to 1 weeks
Number of deaths
All-cause death, cardiovascular death, and procedure-related death
Time frame: Through discharge from hospital, approximately up to 1 weeks
Number of patients with treatment-related complications
Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.
Time frame: 3 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cerebral and Cardiovascular Center, Japan